Quantcast
Home > Quotes > MNTA

Momenta Pharmaceuticals, Inc. Common Stock (MNTA) Quote & Summary Data

MNTA 
$12.4
*  
0.27
2.23%
Get MNTA Alerts
*Delayed - data as of Nov. 21, 2018 11:09 ET  -  Find a broker to begin trading MNTA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    MNTA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 12.38 / $ 12.44
1 Year Target
23.001
Today's High / Low
$ 12.49 / $ 12.14
Share Volume
47,491
50 Day Avg. Daily Volume
728,164
Previous Close
$ 12.13
52 Week High / Low
$ 32.20 / $ 11.72
Market Cap
974,143,504
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -2.01
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.26

Intraday Chart

Shares Traded

Share Volume:
47,491
50 Day Avg. Daily Volume:
728,164

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.01

Trading Range

The current last sale of $12.40 is 5.80% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 12.49 $ 32.20
 Low: $ 12.14 $ 11.72

Company Description (as filed with the SEC)

We are a biotechnology company focused on developing generic versions of complex drugs, biosimilars and novel therapeutics for autoimmune disease. Our approach to drug discovery and development is built around a complex systems analysis platform that we use to obtain a detailed understanding of complex chemical and biologic systems, design product candidates, evaluate the biological function of products and product candidates, and develop reliable and scalable manufacturing processes. The core objective of our platform is to resolve the complexity of molecular structures and related biologic systems. We first map the key measurements needed to obtain comprehensive data on a targeted molecular structure and related biology and then develop a set of analytic tools and methods, including standard, modified and proprietary analytics, to generate the data, including multiple related and complementary, or orthogonal, measures. We also utilize proprietary data analytics software.  ... More ...  


Risk Grade

Where does MNTA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 12.25
Open Date:
Nov. 21, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x